| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000011955 |
| Receipt No. | R000013966 |
| Scientific Title | OMICS analysis of glioma |
| Date of disclosure of the study information | 2013/10/03 |
| Last modified on | 2022/10/10 (Ver. 4) |
| Basic information | ||
| Public title | OMICS analysis of glioma | |
| Acronym | OMICS analysis of glioma | |
| Scientific Title | OMICS analysis of glioma | |
| Scientific Title:Acronym | OMICS analysis of glioma | |
| Region |
|
|
| Condition | ||
| Condition | glioma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | OMIC analysis consists of examinations with Genome,Transcriptome, Proteome, Metabolome, Phenome. By using OMICS analysis of patients with glioma, we will reveal mechanism of disease progression, treatment sensivity. |
| Basic objectives2 | Others |
| Basic objectives -Others | Genomic information |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Genome,Transcriptome, Proteome, Metabolome |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients with glioma | |||
| Key exclusion criteria | no agreement | |||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyoto University Graduate School of Medicine | ||||||
| Division name | Center for Genomic Medicine | ||||||
| Zip code | 6068507 | ||||||
| Address | Shogoinkawahara-cho 53 Kyotoshisakyo-ku, Kyoto-hu, Japan | ||||||
| TEL | 075-751-4157 | ||||||
| fumi@genome.med.kyoto-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyoto University Graduate School of Medicine | ||||||
| Division name | Deaprtment of Neurosurgery | ||||||
| Zip code | 6068507 | ||||||
| Address | Kawahara-cho Shogoin Sakyo-ku, Kyoto | ||||||
| TEL | 075-751-3459 | ||||||
| Homepage URL | https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000011955 | ||||||
| yarakawa@kuhp.kyoto-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kyoto University Graduate School of Medicine
Center for Genomic Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | Government offices of other countries |
| Nationality of Funding Organization | JAPAN |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto University Graduate School and Faculty of Medicine, Ethics Committee |
| Address | Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN |
| Tel | 075-753-4680 |
| ethcom@kuhp.kyoto-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 京都大学医学研究科(京都府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 40 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | OMICS analysis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013966 |